Skip to main content
. 2021 Jan 18;6(1):2381468320978407. doi: 10.1177/2381468320978407

Figure 4.

Figure 4

Maximum acceptable risks of treatment-related depression, brain bleed, and death for different levels of improvement in motor symptoms.